U.S. FDA approves Amylyx ALS drug | Reuters
U.S. FDA approves Amylyx ALS drug | Reuters: The U.S. Food and Drug Administration on Thursday approved Amylyx Pharmaceuticals Inc's drug for slowing progression of ALS, or amyotrophic lateral sclerosis, and potentially delaying death.
Comments
Post a Comment